 | Enanta Pharmaceuticals, Inc. | |||
| NMS : ENTA || Location: United States | ||||
$12.92-0.23 (-1.75%) |
0.09 M | 12.63 - 13.21 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 2.745 M |
| March 28, 2024 | 2.743 M |
| March 15, 2024 | 2.410 M |
| Feb. 29, 2024 | 2.085 M |
| Feb. 15, 2024 | 2.210 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -1.22 | -1.58 | -29.73% |
| 09/30/2023 | -2.19 | -1.33 | 39.26% |
| 06/30/2023 | -2.38 | -1.86 | 21.99% |
| 03/31/2023 | -2.02 | -1.79 | 11.37% |
| 12/31/2022 | -1.63 | -1.39 | 14.56% |
ENTA Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 21.156M | Shares Float | 13.340M |
| Short Float | 2.745M | Market Cap | 273.34M |
| Institution ownership | 0.00% | Insider ownership | 6.100% |
| Earnings Date | 05/06/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -6.57 | Forward EPS | -4.67 |